 BidaskClub upgraded shares of Meridian Bioscience NASDAQ:VIVO from a buy rating to a strong-buy rating in a research report report published on Thursday, BidAskClub reports. Other equities research analysts also recently issued reports about the stock. TheStreet raised shares of Meridian Bioscience from a c rating to a b rating in a research report on ... 